Skip to content

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study

LiveSMART: A Sequential, Multiple Assignment Randomized Trial to Prevent Falls in Patients With Cirrhosis - Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07140120
Acronym
LiveSMART
Enrollment
52
Registered
2025-08-24
Start date
2023-06-13
Completion date
2026-10-01
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Liver, Portal Hypertension

Keywords

Exercise program, Lactulose, Tai-Chi, Fall prevention, Dietary Protein

Brief summary

The LIVE-SMART supplementary study will assess social determinants of health (income, education, neighborhood deprivation), financial burden (out-of-pocket costs, productivity loss), financial distress (patient and caregiver-reported outcomes), and financial toxicity (healthcare utilization) among LIVE-SMART participants and their caregivers. Participants for this supplementary study are participants in the primary study (NCT05794555) and their caregivers.

Detailed description

The supplementary study will augment the primary study the following ways: 1) adding longitudinal questionnaires about financial burden, distress, and toxicity among patients and their caregivers, 2) assessing detailed data and healthcare utilization and associated costs, 3) extending study follow-up by 48 weeks from 24 to 72 weeks.

Interventions

None listed

Sponsors

University of Michigan
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult 18 years of age or older * Informal caregiver of a participant enrolled in LIVE-SMART * English speaking

Exclusion criteria

* Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Comprehensive Score for Financial Toxicity - Functional Assessment of Chronic Illness Therapy v2 (COST-FACIT)Up to 72 weeksFinancial toxicity will be measured using the COST-FACIT v2 tool, a 12-item, validated self-reported scale validated reflecting experiences of the prior 7-days scored 0-44 (with higher scores indicating more toxicity).

Secondary

MeasureTime frameDescription
MedicationsUp to 72 weeksCurrent medications will be recorded at baseline. Changes and/or additions in medications will be recorded at certain follow-up visits.
Work Productivity and Activity Impairment Questionnaire v2 (WPAI)Up to 72 weeksThe WPAI will be used to assess caregivers who report employment, work productivity, absenteeism and presenteeism. Absenteeism is the proportion of work hours lost due to caregiving for someone with cirrhosis subtracted from the total planned work hours in one week before completing the questionnaire. Presenteeism is the proportion of hours worked from the total planned work hours multiplied by the participants impairment in productivity while working (a self-assessed Likert scale from 0 to 10 with 10 indicating complete inability to work). The total work productivity impairment (WPI) is the sum of these two per cent components, ranging from 0 to 100% with 0% indicating no impairment and 100% indicating worst possible impairment. In order to aggregate, productivity loss will be multiplied by the average wage inflated to 2023 dollars.
Out-of-pocket Healthcare Cost Questionnaire (OOP)Up to 72 weeksThe OOP questionnaire combines questions from two assessments - Client Service Receipt Inventory (CSRI) and questions pulled from the Healthy Retirement Survey (HRS). Costs will be measured at the household-level using items from the CSRI. Out-of-pocket costs associated with insurance premiums, hospitalizations/ED visits, outpatient surgeries/procedures, clinic visits, skilled nursing facility /rehabilitation stays, prescriptions, dental care, in-home medical care, and any additional medical expenses or healthcare services will be assessed. The cost of hours of caregiving will be calculated by converting the reported hours of informal care provided in the month prior to each interview to a five-year total number of hours. In order to aggregate, replacement costs will be calculated by multiplying the hours by average costs of home health care services inflated to 2023 dollars (e.g., $28/hour).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORElliott Tapper, MD

University of Michigan

PRINCIPAL_INVESTIGATORMarina Serper, MD, MS

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026